CIRSE Congress 2025 - Dr Fernando Gómez Muñoz (La Fe University and Polytechnic Hospital, Valencia, ES) joins us to discuss findings from stage I of the first-in-human pivotal study aimed to investigate the safety and efficacy of the amber peripheral liquid embolic system in patients requiring peripheral embolisation. Stage I of the study aimed to test the device's safety and stage II aimed to test the device's efficacy.

Interview Questions:
1. What is the reasoning behind the study?
2. Could you tell us about the unique features of the amber peripheral liquid embolic system?
3. What was the study design and patient population?
4. What were the key findings, and were there any unexpected results?
5. What are the take-home messages for practice?
6. Are there specific patient populations who might benefit from additional research on this topic, and what are the next steps?

Recorded virtually from Valencia, 2025.

Editors: Yazmin Sadik, Jordan Rance
Videographers: Dan Brent

Support: This is an independent interview produced by Radcliffe Vascular.